Cargando…
EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers
Epstein-Barr virus (EBV) infects more than 90% of humans worldwide and establishes lifelong latent infection in the hosts. It is closely associated with endemic forms of a wide range of human cancers and directly contributes to the formation of some. Despite its critical role in cancer development,...
Autores principales: | Jiang, Lijun, Xie, Chen, Lung, Hong Lok, Lo, Kwok Wai, Law, Ga-Lai, Mak, Nai-Ki, Wong, Ka-Leung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276081/ https://www.ncbi.nlm.nih.gov/pubmed/30555548 http://dx.doi.org/10.7150/thno.26823 |
Ejemplares similares
-
Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020) -
Reactivation of Epstein–Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn(2+)-chelating function
por: Jiang, Lijun, et al.
Publicado: (2019) -
The Epstein-Barr Virus EBNA1 Protein
por: Frappier, Lori
Publicado: (2012) -
Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013) -
The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)